Dr. Bunge was a top female pioneer in the field of neuroscience, which has historically lacked diversity.
For the majority of her career, Dr. Bunge focused on myelin — a mix of proteins and fatty acids that coats nerve fibers, protecting them and boosting the speed at which they conduct signals.
She discovered that following injuries, myelin receded in a process called demyelination. Alongside her husband, she concluded that demyelination was one reason spinal cord injuries have been so difficult for the body to repair.
The couple determined that myelin could be encouraged to regrow if the affected area was coated in transplanted Schwann cells and paired with drugs and other interventions to promote regeneration.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
